Navigation Links
Kewaunee Scientific Added to Russell Microcap Index
Date:7/8/2008

STATESVILLE, N.C., July 8 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced it has been added to the Russell Microcap Index after the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 27, 2008.

Russell indexes are widely used by investment managers and institutional investors for both index funds and as benchmarks for passive and active investment strategies. The annual reconstitution of the Russell Microcap index captures the 1,000 smallest U.S. stocks in the Russell 2000, plus the next 1,000 stocks as of the end of May.

"We are pleased with our inclusion in this index," said William A. Shumaker, President and Chief Executive Officer. "Russell is an industry leader for stock indexes, and we expect our inclusion will generate greater interest in our stock among institutional investors."

ABOUT RUSSELL INVESTMENT GROUP

Russell Investment Group aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $200 billion in assets under management, Russell serves individual, institutional and advisor clients in more than 40 countries. Russell's indexes are unmanaged and cannot be invested in directly. For more information on Russell indexes, go to http://www.russell.com .

ABOUT KEWAUNEE SCIENTIFIC CORPORATION

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters and domestic manufacturing
'/>"/>

SOURCE Kewaunee Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Kewaunee Scientific Corporation Increases Quarterly Dividend
2. Kewaunee Scientific Reports Results
3. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
4. Thomson Scientific Predicts Nobel Laureates
5. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
6. Thomson Scientific Announces BONDplus for Biological Researchers
7. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
8. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
11. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 57745 1New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 57745 2New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 57745 3New Research Finds Most African American Women with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 57745 4Aurora Capital to Acquire Porex Corporation Leader in Porous Plastic Materials Science 57741 1Aurora Capital to Acquire Porex Corporation Leader in Porous Plastic Materials Science 57741 2Aurora Capital to Acquire Porex Corporation Leader in Porous Plastic Materials Science 57741 3Measuring Pain from the Patients Point of View 57738 1Measuring Pain from the Patients Point of View 57738 2